Tag: AI
-
AI & Antibody Drug Conjugates (ADC)
Antibody drug conjugates (ADCs) are a promising class of therapeutics that combine the specificity of monoclonal antibodies with the potency of small molecule drugs. These conjugates are designed to target specific cancer cells and deliver a cytotoxic payload directly to the tumor, minimizing damage to healthy tissue. While ADCs have shown great potential, their development…
Biotech Informers 